Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Plasma kallikrein-IN-3, a potent inhibitor ( IC 50 : 0.15 μM) of plasma kallikrein, finds application in research related to hereditary angioedema, diabetic macular edema, and diabetic retinopathy [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | Plasma kallikrein-IN-3, a potent inhibitor ( IC 50 : 0.15 μM) of plasma kallikrein, finds application in research related to hereditary angioedema, diabetic macular edema, and diabetic retinopathy [1]. |
In vitro | Plasma kallikrein-IN-3 (example 13, ranging from 1 nM to 100 μM, for 1 hour) effectively reduces plasma kallikrein activity, exhibiting an inhibition concentration (IC) <>50 value of 0.15 μM [1]. |
Molecular Weight | 365.43 |
Formula | C20H23N5O2 |
CAS No. | 1357950-47-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Plasma kallikrein-IN-3 1357950-47-0 inhibitor inhibit